RBCs - potential for sustained release IV formulations Newsletter Article 19 February 2013 Pages: 2 - 2
Aerosolised antibiotics - a possible advantage in patients with AIDS Newsletter Article 19 February 2013 Pages: 2 - 3
Antibacterial prophylaxis recommendation in ITU defended? Newsletter Article 19 February 2013 Pages: 4 - 4
Etretin: proves highly effective in cutaneous lupus erythematosus Newsletter Article 19 February 2013 Pages: 5 - 5
Aceclofenac: produces an effective and well-tolerated analgesic effect for severe odontalgia Newsletter Article 19 February 2013 Pages: 5 - 5
Nisoldipine: improves BP control in patients resistant to or intolerant of nifedipine … Newsletter Article 19 February 2013 Pages: 5 - 6
Millions of Australian dollars could be spent cost effectively on lipidlowering interventions Newsletter Article 19 February 2013 Pages: 6 - 7
Handling Hypertension with Hydrochlorothiazide and ACE Inhibitors Newsletter Article 19 February 2013 Pages: 7 - 8
Once Daily Ceftriaxone is as Effective and Less Expensive… Newsletter Article 19 February 2013 Pages: 9 - 9
Combined Action of Multiple Antihypertensive Mechanisms Newsletter Article 19 February 2013 Pages: 10 - 11
Labetalol in the Treatment of Essential Hypertension Newsletter Article 19 February 2013 Pages: 12 - 13
Postangioplasty Restenosis is not Affected by Antiplatelet Therapy Newsletter Article 19 February 2013 Pages: 13 - 13
Encouraging Results with the Phosphodiesterase Inhibitor Mopidamol Newsletter Article 19 February 2013 Pages: 14 - 14
Transdermal Nitroglycerin Offers No Benefits in Angina Newsletter Article 19 February 2013 Pages: 15 - 15
Abrupt Lithium Withdrawal May Cause Relapse in Bipolar Patients Newsletter Article 19 February 2013 Pages: 15 - 15
Combining the Forces of Neuropsychotherapy and Drug Therapy Newsletter Article 19 February 2013 Pages: 15 - 16
A Detailed Look at Timolol/Pilocarpine Combinations Newsletter Article 19 February 2013 Pages: 16 - 16
Lisinopril: the new drawcard in the ACE-inhibitor pack? Newsletter Article 19 February 2013 Pages: 18 - 18
Teicoplanin: world first introduction of Merrell Dow's antibacterial in Italy and France Newsletter Article 19 February 2013 Pages: 19 - 19
Xamoterol: world first approval for ICIs inotropic partial β-agonist Newsletter Article 19 February 2013 Pages: 19 - 20